Last month that the Vadodara-based company announced that it had received approval for Bosutinib Tablets (Bosutinib Tablets, 100 mg and 500 mg), a drug used in the treatment of blood cancer, from the US FDA.
Last month that the Vadodara-based company announced that it had received approval for Bosutinib Tablets (Bosutinib Tablets, 100 mg and 500 mg), a drug used in the treatment of blood cancer, from the US FDA.